Catalyst Wire Dossier Catalyst Wire Dossier

VIAject 25

· Biodel, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VIAject 25, covering 2015-07-29 to 2015-07-29. Get the full timeline:

Most recent: Clinical Trial Update: A Study Evaluating the Bioequivalence of VIAject®7 Compared to VIAject®25 and Comparing the Pharmacokinetic and Pharmacodynamic Properties of VIAject®7 to Insulin Lispro in Subjects With Type 1 Diabetes Mellitus [Phase 1, Phase 2]

See pricing